Literature DB >> 9850868

Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy.

J D Powell1, J A Ragheb, S Kitagawa-Sakakida, R H Schwartz.   

Abstract

The consequences of T-cell receptor engagement (signal 1) are profoundly affected by the presence or absence of co-stimulation (signal 2). T-cell receptor (TCR) stimulation in the absence of CD28-mediated co-stimulation not only results in little interleukin (IL)-2 production, but induces a long lasting hyporesponsive state known as T-cell clonal anergy. The addition of CD28 ligation to signal 1, on the other hand, results in the production of copious amounts of IL-2. Our laboratory has utilized CD4+ Th 1 clones in an effort to understand the molecular events resulting in enhanced IL-2 production by co-stimulation and the inhibition of IL-2 production in anergy. Our current studies have focused on defining the post-transcriptional effects of CD28-enhanced IL-2 production. The data suggest that a major component of CD28's ability to regulate IL-2 production occurs at the level of message stability and involves the 3'-untranslated region of the message. In terms of anergy, our recent studies support the notion that it is not the result of TCR engagement in the absence of co-stimulation, but rather signal 1 in the absence of IL-2 receptor signaling and proliferation. Furthermore, T-cell anergy appears to be an active negative state in which IL-2 production is inhibited both at the level of signal transduction and by cis-dominant repression at the level of the IL-2 promoter.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850868     DOI: 10.1111/j.1600-065x.1998.tb01246.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  54 in total

Review 1.  Controlling mature CD4+ T cell responses.

Authors:  M E Ozaki; S R Webb
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Educating T cells: early events in the differentiation and commitment of cytokine-producing CD4+ and CD8+ T cells.

Authors:  A Kelso
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes.

Authors:  Stanley T Parish; Jennifer E Wu; Rita B Effros
Journal:  J Clin Immunol       Date:  2010-08-19       Impact factor: 8.317

4.  Histone dynamics on the interleukin-2 gene in response to T-cell activation.

Authors:  Xinxin Chen; Jun Wang; Donna Woltring; Steve Gerondakis; M Frances Shannon
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Co-expression of tumor antigen and interleukin-2 from an adenoviral vector augments the efficiency of therapeutic tumor vaccination.

Authors:  Benjamin Anderschou Holbech Jensen; Maria Abildgaard Steffensen; Karen Nørgaard Nielsen; Jan Pravsgaard Christensen; Allan Randrup Thomsen; Peter Johannes Holst
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

6.  RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Authors:  Hsin-Ching Lin; Peter J Simon; Riza M Ysla; Steven L Zeichner; Gary Brewer; Arnold B Rabson
Journal:  Virology       Date:  2017-05-04       Impact factor: 3.616

Review 7.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3.

Authors:  Stanley T Parish; Jennifer E Wu; Rita B Effros
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.

Authors:  Zengbiao Qi; Xiao-Hong Sun
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 10.  Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion.

Authors:  Greg M Delgoffe; Jonathan D Powell
Journal:  Mol Immunol       Date:  2015-12       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.